Effects of Rhus coriaria L. fruits on lipid profile,Apolipoprotein A , B and Inflammatory factor (hs-CRP) in dyslipidemia patients

Effects of Rhus coriaria L. fruits on lipid profile in dyslipidemia patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201505309662N9

Enrollment

Registered

2015-11-07

Start date

2014-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pure hypercholesterolaemia. Condition 2: Hyperlipidaemia, unspecified. Condition 3: Other disorders of lipoprotein metabolism. Condition 4: Blood pressure. Condition 5: flow-mediated dilatation (FMD). Pure hypercholesterolaemia Hyperlipidaemia, unspecified Other disorders of lipoprotein metabolism Hypertensive diseases Diseases of arteries, arterioles and capillaries

Interventions

Intervention 1: case group: take sumac capsol twice a day after the lunch and dinne for 4 weeks. Intervention 2: control group: take placebo capsol twice a day after the lunch and dinner for 4 weeks.

Treatment - Drugs

Placebo

case group: take sumac capsol twice a day after the lunch and dinne for 4 weeks

control group: take placebo capsol twice a day after the lunch and dinner for 4 weeks

Eligibility

Sex/Gender

All

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : in dyslipidemic patients; subjects aged 35–70 years ; over 5/18 mM cholesterol (200 mg per deciliter); over 3/ 37mM LDL (130 mg dL). exclusion criteria : Individuals with a history of diseases; diabetes; cardiovascular disease; liver and kidney as well as pregnant and breastfeeding; supplements like fish oil which is affect on blood lipids levels; the use of immunosuppressive drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HDL. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;LDL. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;Total cholestrol. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;TG. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;Blood pressure. Timepoint: Before and after 4 weeks. Method of measurement: Sphygmomanometer.;Endothelial Function. Timepoint: Before and after 4 weeks. Method of measurement: Doppler ultrasonography.	—

Measure

Time frame

HDL. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;LDL. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;Total cholestrol. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;TG. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;Blood pressure. Timepoint: Before and after 4 weeks. Method of measurement: Sphygmomanometer.;Endothelial Function. Timepoint: Before and after 4 weeks. Method of measurement: Doppler ultrasonography.

—

Secondary

Measure	Time frame
Inflammatory markers. Timepoint: Before and after 4 weeks. Method of measurement: ELISA Kit.;Weight. Timepoint: Before and after 4 weeks. Method of measurement: scale.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026